Immunization, Hib3 in Papua New Guinea
Papua New Guinea: Immunization, Hib3 was 42.0% in 2024. ▼ Falling
Immunization, Hib3 in Papua New Guinea, 2009–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
In 2024, immunization, hib3 in Papua New Guinea stood at 42.0%.
The figure is up 20.0% on the previous year and down 19.2% over ten years.
Over the whole period, immunization, hib3 in Papua New Guinea peaked at 64.0% in 2009 and was at its lowest, 32.0%, in 2021.
Papua New Guinea ranks 188th of 191 countries on this measure, in the bottom quarter.
The long-run direction has been consistently falling across the 16 years of available data.
Immunization, Hib3 in Papua New Guinea, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 2009 | 64.0% | — |
| 2010 | 55.0% | -14.1% |
| 2011 | 58.0% | +5.5% |
| 2012 | 57.0% | -1.7% |
| 2013 | 59.0% | +3.5% |
| 2014 | 52.0% | -11.9% |
| 2015 | 49.0% | -5.8% |
| 2016 | 46.0% | -6.1% |
| 2017 | 36.0% | -21.7% |
| 2018 | 35.0% | -2.8% |
| 2019 | 35.0% | +0.0% |
| 2020 | 40.0% | +14.3% |
| 2021 | 32.0% | -20.0% |
| 2022 | 37.0% | +15.6% |
| 2023 | 35.0% | -5.4% |
| 2024 | 42.0% | +20.0% |
Papua New Guinea compared with similar countries
- Papua New Guinea's 42.0% is below the median for lower middle income countries, which is 84.0%, 50% of the median. (47 countries reporting)
- Papua New Guinea's 42.0% is below the median for East Asia & Pacific, which is 93.0%, 45% of the median. (29 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 64.0% | 64.0% | 64.0% | 1 |
| 2010s | 48.2% | 35.0% | 59.0% | 10 |
| 2020s | 37.2% | 32.0% | 42.0% | 5 |
Countries ranked near Papua New Guinea
- 186 Azerbaijan 51.0% compare
- 186 Lebanon 51.0% compare
- 188 Central African Republic 42.0% compare
- 188 Yemen 42.0% compare
- 191 Sudan 39.0% compare
More health data for Papua New Guinea
- Un projection of annual infant deaths, annual growth rate -1.77 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.3741 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,127 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2,501 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2023)
- Population ages 00-04, female, annual growth rate 0.27 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0555 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.2621 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is immunization, hib3 in Papua New Guinea?
- Immunization, hib3 in Papua New Guinea was 42.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Papua New Guinea?
- The highest recorded value was 64.0% in 2009.
- What is the lowest immunization, hib3 recorded in Papua New Guinea?
- The lowest recorded value was 32.0% in 2021.
- How does Papua New Guinea rank for immunization, hib3?
- Papua New Guinea ranks 188th out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Papua New Guinea?
- Over the last ten years it is down 19.2%. The long-run trend across the full record is falling.
- Where does this Papua New Guinea data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 16 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.